Clinical Trial Update: Mesenchymal Stem Cells to Treat Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mesenchymal stem cells for treatment of type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Type 2 Diabetes, Mesenchymal Stem Cells | Phase 2 | Status: COMPLETED